Bioabsorbable Stents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

Despite the advent of conventional stents as a major breakthrough in the treatment of peripheral artery disease and coronary artery diseases, these devices permanently remain in the body. Issues with implantation of conventional stents include but are not limited to mechanical blockages, malposition, and late restenosis and so on. A key prediction for interventional cardiology coming out form cardiologists and respective associations is that bioabsorbable stents will eventually replace the conventional bare metal stents. Though dissolving stents have certain drawbacks against metallic stents, it is expected that these challenges will soon be resolved with rapid technological advances. This growth will be further substantiated with growth in clinical data reporting the benefits of bioresorable stents outweighing the current drawbacks.

The purpose of this research study titled ‘Bioabsorbable Stents Market - Growth, Future Prospects, and Competitive Analysis, 2021 - 2029’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global bioabsorbable stents market. This report presents and analyzes the major trends prevalent in the global bioabsorbable stents market and the market size and forecast.

This report categorizes the global bioabsorbable stents market in terms of material, applications, end-users, and geographical distribution. Polymeric and metallic is the basic segmentation of the global bioabsorbable stents market in terms of materials. Based on application types, the global bioabsorbable stents market is categorized into coronary artery diseases and peripheral artery diseases. Additionally, hospitals and ambulatory surgical centers are the end-users considered for the purpose of this study. Market size and forecast for each mentioned segment for the period 2019-2029 is presented in the report along with respective CAGRs for the forecast duration 2021-2029.

Geographically, the global bioabsorbable stents market is best understood by segmenting the market into five major regions and chief region level markets as follows:

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Rest of Europe
• Asia Pacific
• China
• Japan
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2019-2029 along with CAGRs for the forecast period 2021-2029 in this study and are further cross-sectional presented in terms of material, application, end-user and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global bioabsorbable stents market. Competition assessment tools such as Porter’s five forces model, market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global bioabsorbable stents market. The key players profiled in this report are Abbott Laboratories, Arterial Remodeling Technologies, Arterius Limited, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Kyoto Medical Planning, Co., Ltd., Medtronic plc, Microport Scientific Corporation, REVA Medical, Inc., STENTYS SA and Terumo Corporation.

For the purpose of this study, global bioabsorbable stents market is studied for their application in following areas:

• Coronary Artery Diseases
• Peripheral Artery Diseases

Coronary artery disease is one of the prime causes of death worldwide. Percutaneous transluminal coronary angioplasty is the major mechanical intervention used for treating coronary artery disease. Restenosis is a result of vascular expression of the response to injury. Recoiling of arteries during the healing process that is a primary factor responsible for restenosis post angioplasty. Stents offer mechanical scaffolding to the vessel thus eliminating restenosis and vessel recoil. However, continuing the pressure from the stent against the vessel may result in neointimal tissue proliferation due to the stent and thus initiate the recurrence of luminal narrowing due to restenosis. Coronary intervention with bioabsorbable stents has developed renewed interest due to the fact that the need for mechanical support to the healing artery is temporary and prolonged implantation results in disadvantages associated with permanent metallic prosthesis. Stents are beneficial in improving immediate treatment outcomes including the reducing acute vessel occlusion after percutaneous intervention by scaffolding. Scaffolds reduce restenosis by prevention of negative remodeling. The potential advantages of having bioabsorbable stents in the treated site include reduction in the incidence of late stent thrombosis, improving lesion imaging with MRI/CT, ease in performing repeat treatments at the same site, vasomotion restoration and so on. Therefore bioabsorbable stents in coronary artery diseases have a significant role in treating pediatric patients as they allow vessel growth and avoiding future surgical procedure for stent removal.

For the purpose of this study, global bioabsorbable stents market is studied for the following end-users:

• Hospitals
• Ambulatory Surgical Centers

Between hospitals and ambulatory surgical centers, hospitals currently enjoy the dominant position in the bioabsorbable stents market, worldwide. Availability of wide range of procedure options, higher quality care and greater patient footfall are the key factors contributing to the dominance of this segment. Also, hospitals are a more viable option for patients that exhibit a wide range of health status. Conversely, it is expected that the trend on preferring procedures being performed in ambulatory surgical centers will pick pace during the forecast period. Factors such as reduced care time in the facility, lower infection rates, reduced procedure cost and offered convenience to patients will drive the growth of this segment. Procedures in ambulatory centers take about 20% to 25% lesser time as against hospitals, thus exhibiting the potential that such organizations can provide more procedures and thus generate more revenue. Reduced hospital stays also leads to saving significant amount of money to insurance providers and patients alike. Further improvements in the nature of minimally invasive surgical technologies will add to growing the prominence of ambulatory surgical centers in the market.

Geographically, the global bioabsorbable stents market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

North America is the current leader in the global bioabsorbable stents market in terms of both procedure rate and revenue. Early introduction of breakthrough products in the U.S. market, greater awareness between both patients and physicians, evolved reimbursement scenario and healthcare system are the key factors supporting the dominance of North America market. Higher prevalence of coronary artery diseases and peripheral artery diseases also prominently contribute to higher demand for bioabsorbable stents in North America and Europe markets. Additionally, it is expected that Asia Pacific market will witness the fastest growth during the forecast period. Exponential growth in patient pool with chronic peripheral vascular and cardiac diseases, large population base, increasing patient preference for availing safer minimally invasive procedures and improving disposable incomes along with rapid evolution of healthcare infrastructure will play a key role in driving the growth of Asia Pacific bioabsorbable stents market. In addition, hike in the number of ambulatory surgical centers being established along with growing awareness about the associated benefits will also facilitate the growth of bioabsorbable stents market in Asia Pacific. 

The detailed regional classification of the global bioabsorbable stents market is as follows:

• North America (U.S. & Canada)
• Europe (U.K., Germany, and Rest of Europe)
• Asia Pacific (China, Japan, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East and Africa (GCC and Rest of Middle East and Africa)

For the purpose of this study, global bioabsorbable stents market is studied for the following material types:

1. Polymeric Stents

2. Metallic Stents

Polymeric bioabsorbable stents are currently experiencing higher demand in treating cardiovascular diseases. Polymers such as poly-L-lactic acid, polyglycolic acid and polycaprolactone are conventionally used in production of polymer-based stents. Among these, poly-L-lactic acid is most commonly used in medicine and it breaks down lactic acid into natural metabolites, thus enhancing the absorption characteristics of the implant. Use of bioabsorbable polymer coating is generating wide acceptance due to its potential in reducing the need for dual anti-platelet therapies and avoiding the risk of thrombosis. It is also expected that metallic bioabsorbable will witness growth in demand through the forecast period. Iron and magnesium are the prime metals used for making metallic bioabsorbable stents. Higher malleability of iron and magnesium alloys, better understanding of iron’s properties and mechanism in the body in terms of solubility and degradation process and improving awareness are the key factors supporting the rapid growth of metallic bioabsorbable stents segment. Magnesium-based bioabsorbable stents are most commonly used alloy stents because magnesium is an essential element for the human body. Magnesium allows rapid endothelialization and reduced thrombogenicity; in addition, magnesium alloy stents also have reduced degradation time as against iron alloy bioabsorbable stents.


This product will be delivered within 2 business days.